Abstract

COVID-19 is the term used to describe the disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2). Human coronaviruses, first identified in the 1960s, commonly infect humans. Most coronavirus infections are respiratory in nature and primarily affect the upper respiratory tract and the lungs(1). Being new infection clinical picture is not well defined. Clinical course and determinants of outcome are not understood. There is a need to describe the epidemiology of covid 19. To understand the epidemiology of Covid 19 this study is planned. Aim/ Objectives: 1) To identify the clinical profile of COVID-19 POSITIVE patients.2) To analyse associated epidemiological determinants and their relation with outcome. Materials and Methods: Study design: Hospital record-based cross-sectional study (Retrospective study). Study duration: The present study was carried out from May 2022 to July 2022. Results and Conclusion: Out of a total of 395 patients 270 (68%) were male patients, and 125(32%) were female patients. The most common age group was 66-75 years and the least no of patients were in the 86-95 years age group. Most of the patients were admitted for 6-10 days and few patients were admitted for 16-20 and 21-25 days. By using the revised covid-19 clinical management protocol algorithm (Adult) patients were classified. Most of the patients (55.7%) had spo2 (>93%) on admission, and 26.6% of patients had <90% of spo2 on admission. Diabetes Mellitus was the most common comorbidity followed by hypertension and the least chronic obstructive pulmonary disease and rheumatic heart disease. Some of the associated epidemiological factors and their relation with the outcome, comorbidity, spo2 on admission, age, and duration of hospitalization were significantly associated with the outcomes (Discharge, Death, Decision against medical advice i.e., DAMA). Other hands sex and religion were not significantly associated with the outcomes

Description